Safety evaluation of chronic intrathecal administration of heparan N-sulfatase in juvenile cynomolgus monkeys. (Q48489664)

12 February 2018

title

Safety evaluation of chronic intrathecal administration of heparan N-sulfatase in juvenile cynomolgus monkeys. (English)

1 reference

12 February 2018

author name string

Richard W Pfeifer

1

1 reference

12 February 2018

Brian R Felice

2

1 reference

12 February 2018

Robert B Boyd

3

1 reference

12 February 2018

Mark T Butt

4

1 reference

12 February 2018

Juan A Ruiz

5

1 reference

12 February 2018

Michael W Heartlein

6

1 reference

12 February 2018

Pericles Calias

7

1 reference

12 February 2018

publication date

1 June 2012

1 reference

12 February 2018

Drug delivery and translational research

published in

1 reference

12 February 2018

volume

2

1 reference

12 February 2018

issue

3

1 reference

12 February 2018

page(s)

187-200

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1007/s13346-011-0043-1

exact match

0 references

cites work

Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease.

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs--a proof of principle study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

A dose-response study of ibogaine-induced neuropathology in the rat cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Brain endothelial cell-cell junctions: how to "open" the blood brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Morphologic changes associated with intrathecal catheters for direct delivery to the central nervous system in preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-011-0043-1

Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration

21 January 2018

1 reference

12 December 2020

Safety evaluation of chronic intrathecal administration of idursulfase-IT in cynomolgus monkeys

1 reference

12 December 2020

Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial).

1 reference

12 December 2020

Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression

1 reference

12 December 2020

10.1007/S13346-011-0043-1

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

25786866

1 reference

12 February 2018